LDL-cholesterol goal attainment under persistent lipid-lowering therapy in northeast China: Subgroup analysis of the dyslipidemia international study of China (DYSIS-China).

about

LDL-cholesterol goal attainment under persistent lipid-lowering therapy in northeast China: Subgroup analysis of the dyslipidemia international study of China (DYSIS-China).

Item

http://www.wikidata.org/entity/Q47150072

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

LDL-cholesterol goal attainmen ...... study of China (DYSIS-China).

@en

LDL-cholesterol goal attainmen ...... a international study of China

@nl

type

Item

label

LDL-cholesterol goal attainmen ...... study of China (DYSIS-China).

@en

LDL-cholesterol goal attainmen ...... a international study of China

@nl

prefLabel

LDL-cholesterol goal attainmen ...... study of China (DYSIS-China).

@en

LDL-cholesterol goal attainmen ...... a international study of China

@nl

P1476

LDL-cholesterol goal attainmen ...... study of China (DYSIS-China).

@en

P2093

Da-Yi Hu

http://www.w3.org/2001/XMLSchema#string

Jian Sun

http://www.w3.org/2001/XMLSchema#string

Wen Zheng

http://www.w3.org/2001/XMLSchema#string

Xiang-Ting Bu

http://www.w3.org/2001/XMLSchema#string

Xin-Zhu Guo

http://www.w3.org/2001/XMLSchema#string

Yu-Jiao Zhang

http://www.w3.org/2001/XMLSchema#string

Zhan-Quan Li

http://www.w3.org/2001/XMLSchema#string

P2860

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

The prevalence, awareness, treatment, and control of dyslipidemia in northeast China: a population-based cross-sectional survey

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials

Epidemiology of dyslipidemia in Chinese adults: meta-analysis of prevalence, awareness, treatment, and control

Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes.

Rosuvastatin pharmacokinetics and pharmacogenetics in white and Asian subjects residing in the same environment.

High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial.

Contemporary management and attainment of cholesterol targets for patients with dyslipidemia in China.

P304

e8555

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/MD.0000000000008555

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29145263

http://www.w3.org/2001/XMLSchema#string

P921

dyslipidemias

P932

5704808

http://www.w3.org/2001/XMLSchema#string